CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q1 2019 13F Holders as of 3/31/2019

Type / Class
Equity / NAMEN AKT
Number of holders
166
Total Shares
26M
Shares change
+3.92M
Total reported value, excl. options
$929M
Value change
+$146M
Put/Call ratio
1.81
Number of buys
76
Number of sells
-57
Price
$35.72
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.